2016 Mayo Clinic Urology Review
|
|
- Arnold Houston
- 8 years ago
- Views:
Transcription
1 2016 Mayo Clinic Urology Review Please note that all times and speakers are subject to change. All sessions located in Grand Ballroom 2-5 unless otherwise noted. MONDAY, JANUARY 25, :00 a.m. - 11:00 a.m. Exhibit Hall 6:30 p.m. - 8:30 p.m. Welcome Reception 6:00 a.m. - 11:00 a.m. Exhibit Hall 6:50 a.m. - 9:40 a.m. Session 1: Prostate - Malignant I 6:50 a.m. - 7:00 a.m. Introduction Speakers: R. Houston Thompson, MD Stephen A. Boorjian, MD 7:00 a.m. - 7:15 a.m. Utility of Biomarker Panels for Newly Diagnosed Prostate Cancer Speaker: Robert Karnes, MD 7:15 a.m. - 7:30 a.m. Contemporary Prostate MRI Speaker: Adam T. Froemming, MD 7:30 a.m. - 7:45 a.m. Latest on MRI Fusion Biopsy of the Prostate Speaker: Todd C. Igel, MD 7:45 a.m. - 8:00 a.m. Surgical Technique for Robot Prostatectomy - Lessons Learned Speaker: Matthew T. Gettman, MD 8:00 a.m. - 8:15 a.m. Lymph Node Dissection: Why, When, and How Much Speaker: Joseph A. Smith, Jr., MD 8:15 a.m. - 8:30 a.m. ADT Duration for Intermediate/High-Risk Prostate Cancer Speaker: Anthony V. D'Amico, MD, PhD 8:30 a.m. - 8:45 a.m. Latest on Bone Health for Patients on ADT Speaker: Brian Costello, MD 8:45 a.m. - 9:40 a.m. Panel Discussion Panelists: Brian Costello, MD Anthony V. D'Amico, MD, PhD Adam T. Froemming, MD Matthew T. Gettman, MD Todd C. Igel, MD Robert Karnes, MD Joseph A. Smith, Jr., MD 9:40 a.m. - 10:00 a.m. Break / Visit Exhibits 10:00 a.m. - 12:00 p.m. Session 2: Urogynecology Moderator: Daniel S. Elliott, MD 10:00 a.m. - 10:15 a.m. Latest on Interstitial Cystitis and Painful Bladder Syndrome Speaker: J.Quentin Clemens, MD 10:15 a.m. - 10:30 a.m. Medical Management of Overactive Bladder Speaker: Brian J. Linder, MD 10:30 a.m. - 10:45 a.m. Non-Mesh Alternatives for Stress Urinary Incontinence Speaker: Daniel S. Elliott, MD 10:45 a.m. - 11:00 a.m. Management of the Failed Urethral Sling Speaker: Christopher E. Wolter, MD 11:00 a.m. - 11:15 a.m. Robotic Sacrocolpopexy Speaker: Daniel S. Elliott, MD 11:15 a.m. - 12:00 p.m. Panel Discussion Moderator: Daniel S. Elliott, MD Panelists: J.Quentin Clemens, MD Brian J. Linder, MD Christopher E. Wolter, MD 6:30 p.m. - 8:30 p.m. Welcome Reception TUESDAY, JANUARY 26, 2016
2 6:00 a.m. - 11:00 a.m. Exhibit Hall 6:00 a.m. - 11:00 a.m. Exhibit Hall 7:00 a.m. - 9:55 a.m. Session 1: Men's Health Moderator: Mitchell R. Humphreys, MD 7:00 a.m. - 7:15 a.m. Latest on Peyronie's Disease Speaker: Gregory A. Broderick, MD 7:15 a.m. - 7:30 a.m. Simplified Infertility Work-Up Speaker: Landon W. Trost, MD 7:30 a.m. - 7:45 a.m. Latest on Laser Treatment of BPH Speaker: Mitchell R. Humphreys, MD 7:45 a.m. - 8:00 a.m. Novel Non-Laser Treatments of BPH Speaker: Amy E. Krambeck, MD 8:00 a.m. - 8:15 a.m. Testosterone Supplementation: Facts and Fiction Speaker: William F. Young, Jr., MD, MSc 8:15 a.m. - 8:30 a.m. Management of Post Prostatectomy Urinary Incontinence Speaker: Daniel S. Elliott, MD 8:30 a.m. - 8:35 a.m. Long-term Quality of Life and Functional Outcomes among Primary and Secondary Artificial Urinary Sphincter Implantation in Men with Stress Urinary Incontinence Speaker: Boyd R. Viers, MD 8:35 a.m. - 8:50 a.m. Latest on Erectile Dysfunction and Penile Rehabilitation Speaker: Landon W. Trost, MD 8:50 a.m. - 9:05 a.m. Inflatable Penile Prosthesis - Tips and Tricks Speaker: Gregory A. Broderick, MD Moderator: Gregory A. Broderick, MD Panelists: Landon W. Trost, MD Mitchell R. Humphreys, MD Amy E. Krambeck, MD William F. Young, Jr., MD, MSc Daniel S. Elliott, MD 9:55 a.m. - 10:15 a.m. Break / Visit Exhibits 10:15 a.m. - 12:00 p.m. Session 2: Prostate - Malignant II Moderator: Robert Karnes, MD 10:15 a.m. - 10:30 a.m. Adjuvant vs. Salvage Radiation After Prostatectomy Speaker: Anthony V. D'Amico, MD, PhD 10:30 a.m. - 10:45 a.m. Salvage Prostatectomy and Node Dissection After Definitive Treatment Speaker: Robert Karnes, MD 10:45 a.m. - 11:00 a.m. Castration-Resistant Prostate Cancer: An AUA Guideline Based Approach Speaker: Michael S. Cookson, MD, MMHC 11:00 a.m. - 11:15 a.m. Latest on C11 Choline PET Scan Speaker: Eugene D. Kwon, MD 11:15 a.m. - 12:00 p.m. Panel Discussion Moderator: Robert Karnes, MD Panelists: Anthony V. D'Amico, MD, PhD Michael S. Cookson, MD, MMHC Eugene D. Kwon, MD WEDNESDAY, JANUARY 27, :00 a.m. - 11:00 a.m. Exhibit Hall 6:00 a.m. - 11:00 a.m. Exhibit Hall 7:00 a.m. - 10:00 a.m. Session 1: Kidney - Malignant Moderator: Bradley C. Leibovich, MD 7:00 a.m. - 7:15 a.m. Latest on Ablation for Renal Masses Speaker: Thomas D. Atwell, MD 9:05 a.m. - 9:55 a.m. Panel Discussion
3 7:15 a.m. - 7:45 a.m. Debate: Renal Mass Biopsy Should be Standard for Active Surveillance 7:15 a.m. - 7:30 a.m. Pro Debater: Alexander Kutikov, MD, FACS 7:30 a.m. - 7:45 a.m. Con Debater: Bradley C. Leibovich, MD 7:45 a.m. - 8:00 a.m. Robotic Partial Nephrectomy: Novice to Expert in 15 minutes Speaker: David D. Thiel, MD 8:00 a.m. - 8:15 a.m. Lymph Node Dissection: Why, When, and How Much Speaker: Christopher G. Wood, MD, FACS 8:15 a.m. - 8:30 a.m. Update on Systemic Therapy for Metastatic Renal Cell Carcinoma Speaker: Brian Costello, MD 8:30 a.m. - 8:45 a.m. Contemporary Cytoreductive Nephrectomy and Metastasectomy Speaker: Christopher G. Wood, MD, FACS 8:45 a.m. - 9:00 a.m. Current and Future of Immunotherapy for Renal Cell Carcinoma Speaker: Eugene D. Kwon, MD 9:00 a.m. - 10:00 a.m. Panel Discussion Moderator: Christopher G. Wood, MD, FACS Panelists: Bradley C. Leibovich, MD Thomas D. Atwell, MD Alexander Kutikov, MD, FACS David D. Thiel, MD Brian Costello, MD Eugene D. Kwon, MD 10:00 a.m. - 10:20 a.m. Break / Visit Exhibits 10:20 a.m. - 12:00 p.m. Session 2: Testis Moderator: Bradley C. Leibovich, MD 10:20 a.m. - 10:35 a.m. Ultrasound Evaluation of Scrotal Lesions and Radiographic Pearls Speaker: Bernard F. King, MD 10:35 a.m. - 10:50 a.m. Stage I/IIA Germ Cell Tumors Speaker: R. Houston Thompson, MD 10:50 a.m. - 11:05 a.m. Indications for Post-Chemo Retroperitoneal Lymph Node Dissection Speaker: Bradley C. Leibovich, MD 11:05 a.m. - 11:20 a.m. Latest on Chemotherapy for Germ Cell Tumors Speaker: Dean Bajorin, MD 11:20 a.m. - 12:00 p.m. Panel Discussion Moderator: Bradley C. Leibovich, MD Panelists: R. Houston Thompson, MD Dean Bajorin, MD Christopher G. Wood, MD, FACS THURSDAY, JANUARY 28, :00 a.m. - 11:00 a.m. Exhibit Hall 7:00 p.m. - 10:00 p.m. Farewell Banquet 6:00 a.m. - 11:00 a.m. Exhibit Hall 7:00 a.m. - 10:00 a.m. Session 1: Bladder - Malignant 7:00 a.m. - 7:15 a.m. What To Do When BCG Does Not Work? Speaker: Michael S. Cookson, MD, MMHC 7:15 a.m. - 7:30 a.m. Variant Histology and Pathologic Re-Review in Bladder Cancer Speaker: John C. Cheville, MD 7:30 a.m. - 7:45 a.m. Competing Comorbidities in Bladder Cancer Speaker: Matthew K. Tollefson, MD 7:45 a.m. - 8:30 a.m. Debate: Optimal Treatment for Localized Muscle Invasive Bladder Cancer 7:45 a.m. - 8:00 a.m. Trimodality Therapy Debater: C. Richard Choo, MD 8:00 a.m. - 8:15 a.m. Cystectomy +/- Neoadjuvant Chemo Debater: Joseph A. Smith, Jr., MD 8:15 a.m. - 8:30 a.m. Robotic Cystectomy +/- Neoadjuvant Chemo Debater: Igor Frank, MD 8:30 a.m. - 8:45 a.m. Robotic/Laparoscopic Nephroureterectomy: Tips and Tricks Speaker: Paul E. Andrews, MD
4 8:45 a.m. - 9:00 a.m. Neoadjuvant Chemotherapy: Why and When? Speaker: Dean Bajorin, MD 9:00 a.m. - 10:00 a.m. Panel Discussion Panelists: Michael S. Cookson, MD, MMHC John C. Cheville, MD C. Richard Choo, MD Joseph A. Smith, Jr., MD Igor Frank, MD Paul E. Andrews, MD Dean Bajorin, MD 10:00 a.m. - 10:20 a.m. Break / Visit Exhibits 10:20 a.m. - 12:00 p.m. Session 2: Urolithiasis Moderator: Matthew T. Gettman, MD 10:20 a.m. - 10:35 a.m. Medical Management of Calcium Stones Speaker: Margaret S. Pearle, MD, PhD 10:35 a.m. - 10:50 a.m. Medical Management of Non- Calcium Stones Speaker: Amy E. Krambeck, MD 10:50 a.m. - 11:05 a.m. Latest on Ureteroscopy Speaker: Margaret S. Pearle, MD, PhD 11:05 a.m. - 11:20 a.m. Latest on PCNL Speaker: Mitchell R. Humphreys, MD 11:20 a.m. - 12:00 p.m. Panel Discussion Moderator: Matthew T. Gettman, MD Panelists: Margaret S. Pearle, MD, PhD Amy E. Krambeck, MD Mitchell R. Humphreys, MD 7:00 p.m. - 10:00 p.m. Farewell Banquet FRIDAY, JANUARY 29, :00 a.m. - 11:00 a.m. Exhibit Hall 6:00 a.m. - 11:00 a.m. Exhibit Hall 7:00 a.m. - 9:40 a.m. Session 1: Trauma, Infection, and Inflammation 7:00 a.m. - 7:15 a.m. Pediatric Emergencies for the Adult Urologist Speaker: Candace F. Granberg, MD 7:15 a.m. - 7:30 a.m. Latest in Management of Prostatitis Speaker: J.Quentin Clemens, MD 7:30 a.m. - 7:45 a.m. Military Trauma and Trauma Guidelines Speaker: Joseph Sterbis, MD 7:45 a.m. - 8:00 a.m. Management of Refractory Hematuria Speaker: Stephen A. Boorjian, MD 8:00 a.m. - 8:15 a.m. Management of Recurrent UTI's Speaker: J.Quentin Clemens, MD 8:15 a.m. - 8:30 a.m. Primer on Genitourinary Dermatology Speaker: Christian L. Baum, MD 8:30 a.m. - 8:45 a.m. Laparoscopic/Robotic Nephrectomy in Challenging Situations Speaker: Paul E. Andrews, MD 8:45 a.m. - 9:00 a.m. Catastrophic Laparoscopic Complications Speaker: David D. Thiel, MD 9:00 a.m. - 9:40 a.m. Panel Discussion Panelists: Candace F. Granberg, MD J.Quentin Clemens, MD Joseph Sterbis, MD Stephen A. Boorjian, MD Paul E. Andrews, MD David D. Thiel, MD Christian L. Baum, MD 9:40 a.m. - 10:00 a.m. Break / Visit Exhibits (Audience Response Vote for Future Meetings) 10:00 a.m. - 12:00 p.m. Session 2: Medical Practice 10:00 a.m. - 10:15 a.m. Work-up of Adrenal Incidentaloma Speaker: William F. Young, Jr., MD, MSc 10:15 a.m. - 10:30 a.m. How to Utilize Social Media in Current Medical Practice Speaker: Alexander Kutikov, MD, FACS
5 10:30 a.m. - 10:45 a.m. Survivorship Issues in Cancer Patients Speaker: Carrie Thompson, MD 10:45 a.m. - 11:00 a.m. Latest on Contrast Administration with CT/MRI Panelist: Robert P. Hartman, MD 11:00 a.m. - 11:15 a.m. Video Visits for Outpatient Urologic Practice Speaker: Matthew T. Gettman, MD 11:15 a.m. - 11:30 a.m. Options for Androgen Deprivation and Managing Side Effects Speaker: Shin Egawa, MD 11:30 a.m. - 12:00 p.m. Panel Discussion Panelists: William F. Young, Jr., MD, MSc Alexander Kutikov, MD, FACS Carrie Thompson, MD Matthew T. Gettman, MD Robert P. Hartman, MD Todd C. Igel, MD
6
These rare variants often act aggressively and may respond differently to therapy than the more common prostate adenocarcinoma.
Prostate Cancer OVERVIEW Prostate cancer is the second most common cancer diagnosed among American men, accounting for nearly 200,000 new cancer cases in the United States each year. Greater than 65% of
More informationCombined Harvard Urologic Oncology Fellowship Program
Combined Harvard Urologic Oncology Fellowship Program 1 Goal: Department of Urology To reduce the disease burden for patients with urologic issues by improving: Clinical Care Teaching Research 2 History
More informationRotolo, Howard & Leitner Urologic Associates
Visit us now online at www.njphysician.org JULY 2012 JULY 2012 Rotolo, Howard & Leitner Urologic Associates The Physicians of This Innovative Practice Speak Out on the PSA Screening Controversy and Other
More informationProstate Cancer. Treatments as unique as you are
Prostate Cancer Treatments as unique as you are UCLA Prostate Cancer Program Prostate cancer is the second most common cancer among men. The UCLA Prostate Cancer Program brings together the elements essential
More informationKidney Cancer OVERVIEW
Kidney Cancer OVERVIEW Kidney cancer is the third most common genitourinary cancer in adults. There are approximately 54,000 new cancer cases each year in the United States, and the incidence of kidney
More informationMetro Urology. VOLUME 1 WINTER 2012 MAIN PHONE: (713) 351-0630 HMUtx.com. Houston Metro Urology Opens New Surgical Center
HMU Houston VOLUME 1 WINTER 2012 MAIN PHONE: (713) 351-0630 Houston Opens New Surgical Center New HMU surgical center features six new state-of-the-art operating suites Houston (HMU) unveiled its new 11,500-squarefoot
More informationBeyond the PSA: Genomic Testing in Localized Prostate Cancer
Beyond the PSA: Genomic Testing in Localized Prostate Cancer Kelvin A. Moses, MD, PhD Vanderbilt University Medical Center Wednesday, December 2, 2015 5:00 p.m. ET/2:00 p.m. PT About ZERO ZERO s mission
More informationThomas A. Kollmorgen, M.D. Oregon Urology Institute
Thomas A. Kollmorgen, M.D. Oregon Urology Institute None 240,000 new diagnosis per year, and an estimated 28,100 deaths (2012) 2 nd leading cause of death from cancer in U.S.A. Approximately 1 in 6 men
More informationDIAGNOSIS OF PROSTATE CANCER
DIAGNOSIS OF PROSTATE CANCER Determining the presence of prostate cancer generally involves a series of tests and exams. Before starting the testing process, the physician will ask questions about the
More informationLectures Hands On Simula on Roundtable Discussions Panel Discussion August 14, 2015
presents Kidney Stones: Medical, Surgical and Dietary Approaches Lectures Hands On Simula on Roundtable Discussions Panel Discussion August 14, 2015 This ac vity has been approved for AMA PRA Category
More informationIssues Concerning Development of Products for Treatment of Non-Metastatic Castration- Resistant Prostate Cancer (NM-CRPC)
Issues Concerning Development of Products for Treatment of Non-Metastatic Castration- Resistant Prostate Cancer (NM-CRPC) FDA Presentation ODAC Meeting September 14, 2011 1 Review Team Paul G. Kluetz,
More information7. Prostate cancer in PSA relapse
7. Prostate cancer in PSA relapse A patient with prostate cancer in PSA relapse is one who, having received a primary treatment with intent to cure, has a raised PSA (prostate-specific antigen) level defined
More informationA bladder cancer glossary
A bladder cancer glossary We ve put together a list of the medical terms you might hear people use when they talk about bladder cancer. Abdomen The middle part of your body that contains your stomach,
More informationPROSTATE CANCER 101 WHAT IS PROSTATE CANCER?
PROSTATE CANCER 101 WHAT IS PROSTATE CANCER? Prostate cancer is cancer that begins in the prostate. The prostate is a walnut-shaped gland in the male reproductive system located below the bladder and in
More informationUs TOO University Presents: Understanding Diagnostic Testing
Us TOO University Presents: Understanding Diagnostic Testing for Prostate Cancer Patients Today s speaker is Manish Bhandari, MD Program moderator is Pam Barrett, Us TOO International Made possible by
More informationinnovations Health Services Research: Identifying Gaps Between Standards and Practices pg 4 in Urology
Winter 2013 innovations in Urology Health Services Research: Identifying Gaps Between Standards and Practices pg 4 A survivorship program optimizes post-prostatectomy quality of life pg 3 Surgeon-scientists
More informationThe Center for Prostate Cancer. Personalized Treatment. Clinical Excellence.
The Center for Prostate Cancer Personalized Treatment. Clinical Excellence. The Center for Prostate Cancer Leaders in Prostate Cancer Treatment and Research The Center for Prostate Cancer at the North
More informationdedicated to curing BREAST CANCER
dedicated to curing BREAST CANCER When you are diagnosed with breast cancer, you need a team of specialists who will share their knowledge of breast disease and the latest treatments available. At Cancer
More informationCMScript. Member of a medical scheme? Know your guaranteed benefits! Issue 7 of 2014
Background CMScript Member of a medical scheme? Know your guaranteed benefits! Issue 7 of 2014 Prostate cancer is second only to lung cancer as the leading cause of cancer-related deaths in men. It is
More informationMetastatic Renal Cell Carcinoma: Staging and Prognosis of Three Separate Cases.
Metastatic Renal Cell Carcinoma: Staging and Prognosis of Three Separate Cases. Abstract This paper describes the staging, imaging, treatment, and prognosis of renal cell carcinoma. Three case studies
More informationRotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma
Rotation Specific Goals & Objectives: University Health Network-Princess Margaret Hospital/ Sunnybrook Breast/Melanoma Medical Expert: Breast Rotation Specific Competencies/Objectives 1.0 Medical History
More informationLung Cancer Treatment Guidelines
Updated June 2014 Derived and updated by consensus of members of the Providence Thoracic Oncology Program with the aid of evidence-based National Comprehensive Cancer Network (NCCN) national guidelines,
More informationProstate Cancer Treatment: What s Best for You?
Prostate Cancer Treatment: What s Best for You? Prostate Cancer: Radiation Therapy Approaches I. Choices There is really a variety of options in prostate cancer management overall and in radiation therapy.
More informationEarly Prostate Cancer: Questions and Answers. Key Points
CANCER FACTS N a t i o n a l C a n c e r I n s t i t u t e N a t i o n a l I n s t i t u t e s o f H e a l t h D e p a r t m e n t o f H e a l t h a n d H u m a n S e r v i c e s Early Prostate Cancer:
More informationRenal Cell Carcinoma The New Frontier (To boldly go... ) Sean A. Pierre, MD, RCPSC (Urology)
The New Frontier (To boldly go... ) Sean A. Pierre, MD, RCPSC (Urology) QUEENSWAY CARLETON HOSPITAL DIVISION OF UROLOGY NEPEAN, ON, CANADA Disclosures None Objectives Advances in the field of Renal Cell
More informationOpen the Flood Gates Urinary Obstruction and Kidney Stones. Dr. Jeffrey Rosenberg Dr. Emilio Lastarria Dr. Richard Kasulke
Open the Flood Gates Urinary Obstruction and Kidney Stones Dr. Jeffrey Rosenberg Dr. Emilio Lastarria Dr. Richard Kasulke Nephrology vs. Urology Nephrologist a physician who has been trained in the diagnosis
More informationA Woman s Guide to Prostate Cancer Treatment
A Woman s Guide to Prostate Cancer Treatment Supporting the man in your life Providing prostate cancer support and resources for women and families WOMEN AGAINST PROSTATE CANCER A Woman s Guide to Prostate
More informationSmoking and misuse of certain pain medicines can affect the risk of developing renal cell cancer.
Renal cell cancer Renal cell cancer is a disease in which malignant (cancer) cells form in tubules of the kidney. Renal cell cancer (also called kidney cancer or renal adenocarcinoma) is a disease in which
More informationOKLAHOMA PROSTATE CANCER SYMPOSIUM
OKLAHOMA PROSTATE CANCER Saturday, September 26, 2015 Stephenson Cancer Center, OU Health Sciences Center Oklahoma City, OK Earn up to 5.5 AMA PRA Category 1 Credits TM Register online: cme.ouhsc.edu Michael
More informationFocus on PSA Screening for Prostate Cancer Vol. 28 Supplement, February 2012. Prostate Cancer: Should We Be Screening?
Focus on PSA Screening for Prostate Cancer Vol. 28 Supplement, February 2012 Prostate Cancer: Should We Be Screening? INSIDE THIS ISSUE 2 Why the Controversy? 3 Active Surveillance 4 The Radical Prostatectomy
More informationBest of San Antonio Breast Cancer Symposium
Best of San Antonio Breast Cancer Symposium 11:45 am - 5:00 pm 5800 Rockside Woods Blvd. About the Course The San Antonio Breast Cancer Symposium is an international meeting of laboratory and clinical
More informationPROSTATE CANCER. Get the facts, know your options. Samay Jain, MD, Assistant Professor,The University of Toledo Chief, Division of Urologic Oncology
PROSTATE CANCER Get the facts, know your options Samay Jain, MD, Assistant Professor,The University of Toledo Chief, Division of Urologic Oncology i What is the Prostate? Unfortunately, you have prostate
More informationRunning Head: PROSTATE CANCER TREATMENTS AND CASE STUDY 1. Prostate Cancer: Treatments and Case Study
Running Head: PROSTATE CANCER TREATMENTS AND CASE STUDY 1 Prostate Cancer: Treatments and Case Study November 13, 2012 PROSTATE CANCER 2 Abstract Prostate cancer affected 192,280 men in the United States
More informationAdvances in Prostate Imaging and Ablative Treatment of Prostate Cancer
Provided by the NYU Post-Graduate Medical School Advances in Prostate Imaging and Ablative Treatment of Prostate Cancer Friday Saturday June 19 20, 2015 New York City Register online: med.nyu.edu/cme/mi
More informationNEOPLASMS OF KIDNEY (RENAL CELL CARCINOMA) And RENAL PELVIS (TRANSITIONAL CELL CARCINOMA)
NEOPLASMS OF KIDNEY (RENAL CELL CARCINOMA) And RENAL PELVIS (TRANSITIONAL CELL CARCINOMA) Merat Esfahani, MD Medical Oncologist, Hematologist Cancer Liaison Physician SwedishAmerican Regional Cancer Center
More informationNon-Small Cell Lung Cancer Treatment Comparison to NCCN Guidelines
Non-Small Cell Lung Cancer Treatment Comparison to NCCN Guidelines April 2008 (presented at 6/12/08 cancer committee meeting) By Shelly Smits, RHIT, CCS, CTR Conclusions by Dr. Ian Thompson, MD Dr. James
More informationProstate Cancer Guide. A resource to help answer your questions about prostate cancer
Prostate Cancer Guide A resource to help answer your questions about prostate cancer Thank you for downloading this guide to prostate cancer treatment. We know that all the information provided online
More informationNewly Diagnosed Prostate Cancer: Understanding Your Risk
Newly Diagnosed Prostate Cancer: Understanding Your Risk When the urologist calls with the life-changing news that your prostate biopsy is positive for prostate cancer, an office appointment is made to
More informationPSA Screening for Prostate Cancer Information for Care Providers
All men should know they are having a PSA test and be informed of the implications prior to testing. This booklet was created to help primary care providers offer men information about the risks and benefits
More informationprostate cancer: A Success Story
prostate cancer: A Success Story Prostate cancer is the most common cancer in human beings. That is, even though prostate cancer occurs only in men, the number of men with prostate cancer exceeds the combined
More informationAn Introduction to PROSTATE CANCER
An Introduction to PROSTATE CANCER Being diagnosed with prostate cancer can be a life-altering experience. It requires making some very difficult decisions about treatments that can affect not only the
More informationThe Business of Prostate Cancer Care: A Clinician-Researcher s Perspective
The Business of Prostate Cancer Care: A Clinician-Researcher s Perspective David F. Penson, MD, MPH Departments of Urology and Preventive Medicine Keck School of Medicine University of Southern California
More informationGuidelines for Management of Renal Cancer
Guidelines for Management of Renal Cancer Date Approved by Network Governance July 2012 Date for Review July 2015 Changes Between Versions 2 and 3 Section 5 updated bullets 5.3 and 5.4 Section 6 updated
More informationTO SCREEN OR NOT TO SCREEN: THE PROSTATE CANCER
TO SCREEN OR NOT TO SCREEN: THE PROSTATE CANCER DILEMMA Thomas J Stormont MD January 2012 http://www.youtube.com/watch?v=8jd 7bAHVp0A&feature=related related INTRODUCTION A government health panel (the
More informationHEALTH NEWS PROSTATE CANCER THE PROSTATE
HEALTH NEWS PROSTATE CANCER THE PROSTATE Prostate comes from the Greek meaning to stand in front of ; this is very different than prostrate which means to lie down flat. The prostate is a walnut-sized
More informationMODULE 8: PROSTATE CANCER: SCREENING & MANAGEMENT
MODULE 8: PROSTATE CANCER: SCREENING & MANAGEMENT KEYWORDS: Prostate cancer, PSA, Screening, Radical Prostatectomy LEARNING OBJECTIVES At the end of this clerkship, the medical student will be able to:
More informationGENERAL CODING. When you review old cases that were coded to unknown, make corrections based on guidelines in effect at the time of diagnosis.
GENERAL CODING When you review old cases that were coded to unknown, make corrections based on guidelines in effect at the time of diagnosis. Exception: You must review and revise EOD coding for prostate
More informationProstate Cancer Action Plan: Choosing the treatment that s right for you
Prostate Cancer Action Plan: Choosing the treatment that s right for you Segment 1: Introduction Trust me, there's a better way to choose a treatment for your prostate cancer. Watching this program is
More informationLIvING WITH Prostate Cancer
Living with Prostate Cancer A Common Cancer in Men If you ve been diagnosed with prostate cancer, it s normal to be concerned about your future. It may help you to know that this disease can often be cured
More informationTreatment and Surveillance of Non- Muscle Invasive Bladder Cancer
Treatment and Surveillance of Non- Muscle Invasive Bladder Cancer David Josephson, MD FACS Fellowship Director, Urologic Oncology and Robotic Surgery Program Staging Most important in risk assessment and
More informationRadiation Therapy for Prostate Cancer: Treatment options and future directions
Radiation Therapy for Prostate Cancer: Treatment options and future directions David Weksberg, M.D., Ph.D. PinnacleHealth Cancer Institute September 12, 2015 Radiation Therapy for Prostate Cancer: Treatment
More informationRoswell Park scientists and clinicians:
The Prostate Cancer Center at Roswell Park Connects You to Nationally Recognized Experts for State-of-the-Art Treatment Options and Compassionate, Evidence-based Care Founded in 1898, Roswell Park Cancer
More informationGeneral Rules SEER Summary Stage 2000. Objectives. What is Staging? 5/8/2014
General Rules SEER Summary Stage 2000 Linda Mulvihill Public Health Advisor NCRA Annual Meeting May 2014 National Center for Chronic Disease Prevention and Health Promotion Division of Cancer Prevention
More informationHow is Prostate Cancer Diagnosed?
Prostate cancer: English Prostate cancer This fact sheet is about how prostate cancer is diagnosed and treated. We also have fact sheets in your language about chemotherapy, radiotherapy, surgery, side
More informationBLADDER HEALTH. Non-Muscle Invasive Bladder Cancer: A Patient Guide
BLADDER HEALTH Non-Muscle Invasive Bladder Cancer: A Patient Guide What is the Bladder? What is Cancer? The bladder is a balloon-shaped organ in your pelvic* area that stores urine and is made up of four
More informationDetection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical
Summary. 111 Detection and staging of recurrent prostate cancer is still one of the important clinical problems in prostate cancer. A rise in PSA or biochemical recurrence (BCR) is the first sign of recurrent
More informationEffective Health Care Program
Comparative Effectiveness Review Number 152 Effective Health Care Program Treatment of Nonmetastatic Muscle-Invasive Bladder Cancer Executive Summary Background Nature and Burden of Nonmetastatic Muscle-Invasive
More informationProstate Cancer. There is no known association with an enlarged prostate or benign prostatic hyperplasia (BPH).
Prostate Cancer Definition Prostate cancer is cancer that starts in the prostate gland. The prostate is a small, walnut-sized structure that makes up part of a man's reproductive system. It wraps around
More informationMetastatic Cervical Cancer s/p Radiation Therapy, Radical Hysterectomy and Attempted Modified Internal Hemipelvectomy
Metastatic Cervical Cancer s/p Radiation Therapy, Radical Hysterectomy and Attempted Modified Internal Hemipelvectomy Sarah Hutto,, MSIV Marc Underhill, M.D. January 27, 2009 Past History 45 yo female
More informationAnalysis of Prostate Cancer at Easter Connecticut Health Network Using Cancer Registry Data
The 2014 Cancer Program Annual Public Reporting of Outcomes/Annual Site Analysis Statistical Data from 2013 More than 70 percent of all newly diagnosed cancer patients are treated in the more than 1,500
More informationFocal therapy for prostate cancer: seriously or seriously? Disclosures
Focal therapy for prostate cancer: seriously or seriously? Mitchell Kamrava, MD Assistant Clinical Professor Department of Radiation Oncology University of California Los Angeles Disclosures Speaking honorarium
More informationProstate Cancer. Patient Information
Prostate Cancer Patient Information 1 The Prostate & Prostate Cancer The prostate is a small gland in the male reproductive system, approximately the size and shape of a walnut. It is located directly
More informationRobotic Radical Prostatectomy: What s s the Advantage? Matthew T. Gettman, M.D. Associate Professor Department of Urology
Robotic Radical Prostatectomy: What s s the Advantage? Matthew T. Gettman, M.D. Associate Professor Department of Urology Prostate Cancer Epidemiology: 2009 Estimated new cases: 230,000 Estimated deaths:
More informationClinical Trials and Radiation Treatment. Gerard Morton Odette Cancer Centre Sunnybrook Research Institute University of Toronto
Clinical Trials and Radiation Treatment Gerard Morton Odette Cancer Centre Sunnybrook Research Institute University of Toronto What I will cover.. A little about radiation treatment The clinical trials
More informationCONTEMPORARY MANAGEMENT OF RENAL ANGIOMYOLIPOMA
CONTEMPORARY MANAGEMENT OF RENAL ANGIOMYOLIPOMA Stephen A. Boorjian, MD Professor of Urology Vice Chair of Research Director, Urologic Oncology Fellowship Department of Urology Mayo Clinic, Rochester,
More informationFUS 65 th Annual Meeting Scientific Program Schedule
THURSDAY, AUGUST 29, 2013 FUS 65 th Annual Meeting Scientific Program Schedule *Speakers and times are subject to change *All sessions will be located in Grand Ballroom unless otherwise noted 4:00 p.m.
More informationUrology Nurse Practitioner Urology Research Nurse Australian Prostate Cancer Research Centre Epworth November 18, 2011
Urology Nurse Practitioner Helen Crowe Urology Nurse Practitioner Urology Research Nurse Australian Prostate Cancer Research Centre Epworth November 18, 2011 Nurse Practitioner Registered nurse who has
More informationCancer doesn t care but we do. 2010 Cancer Annual Report
Cancer doesn t care but we do. 2010 Cancer Annual Report The Cancer Committee of CHRISTUS St. Patrick Hospital is proud to present its 2010 Annual Report. The Community Hospital Comprehensive Cancer Program
More informationBreast Cancer. CSC Cancer Experience Registry Member, breast cancer
ESSENTIALS Breast Cancer Take things one step at a time. Try not to be overwhelmed by the tidal wave of technical information coming your way. Finally you know your body best; you have to be your own advocate.
More informationST JOSEPH REGIONAL HEALTH CENTER LUNG CANCER ANALYSIS Incidence, Diagnosis, Treatment and Survival
ST JOSEPH REGIONAL HEALTH CENTER LUNG CANCER ANALYSIS Incidence, Diagnosis, Treatment and Survival It is logical that the Cancer Program Committee choose to review the Lung Site, as Lung is the second
More informationAnnual Meeting. Texas Urological Society. Attendee Registration. June 7 9, 2012 Barton Creek Hotel Austin, Texas. You are invited to register for the
You are invited to register for the 2012 Annual Meeting June 7 9, 2012 Barton Creek Hotel Austin, Texas Attendee Registration Educational Program jointly sponsored by Texas Medical Association and the.
More informationGUIDELINES FOR THE MANAGEMENT OF LUNG CANCER
GUIDELINES FOR THE MANAGEMENT OF LUNG CANCER BY Ali Shamseddine, MD (Coordinator); as04@aub.edu.lb Fady Geara, MD Bassem Shabb, MD Ghassan Jamaleddine, MD CLINICAL PRACTICE GUIDELINES FOR THE TREATMENT
More informationwww.downstatesurgery.org
Male Breast Cancer Rabih Nemr MD Kings County Hospital August 2008 ACGME Core Competencies 1 Patient t Care Medical Knowledge 2 g 3 4 Practice Based Learning/Improvement Interpersonal Communication Skills
More informationProgram Chairs: Robert W. Holloway, MD and Martin Martino, MD Speakers and times are subject to change
FRIDAY, FEBRUARY 20, 2015 Program Chairs: and Martin Martino, MD Speakers and times are subject to change 6:00 a.m. 6:00 p.m. Registration/Information Desk /L Foyer 6:00 a.m. 6:00 p.m. Speaker Ready Area
More informationProstate Cancer- Epidemiology. Risk Factors for Prostate Cancer. Prostate Cancer- Epidemiology. Prostate Cancer and Genetics
Prostate Cancer Gretchen Dickson, MD, MBA, FAAFP ACTIVITY DISCLAIMER The material presented here is being made available by the American Academy of Family Physicians for educational purposes only. This
More informationBasics on Treatment for prostate cancer
Basics on Treatment for prostate cancer SECTION 1: TREATMENTS This pamphlet provides information about different treatments for prostate cancer including what to expect and any risks and side-effects.
More informationWhat You Need to Know for Better Bone Health
What You Need to Know for Better Bone Health A quick lesson about bones: Why healthy bones matter The healthier your bones The more active you can be Bone health has a major effect on your quality of life
More informationUnderstanding Prostate Cancer. The Urology Group Guide for Newly Diagnosed Patients. Advanced Care. Improving Lives.
Understanding Prostate Cancer The Urology Group Guide for Newly Diagnosed Patients Advanced Care. Improving Lives. UNDERSTANDING PROSTATE CANCER The Urology Group has created this publication to provide
More informationAdvanced Prostate Cancer Treatments
Advanced Prostate Cancer Treatments Guest Expert: Kevin, DO Associate Professor of Medical Oncology, Yale Cancer Center www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer Center Answers with
More informationBreast Health Program
Breast Health Program Working together, for your health. Breast Health Program The Breast Health Program at The University of Arizona Cancer Center offers patients a personalized approach to breast cancer,
More informationProstate Cancer In-Depth
Prostate Cancer In-Depth Introduction Prostate cancer is the most common visceral malignancy among American men. In the year 2003, there are expected to be 220,000 new cases and nearly 29,000 deaths in
More informationRadiation Therapy for Prostate Cancer
Radiation Therapy for Prostate Cancer Introduction Cancer of the prostate is the most common form of cancer that affects men. About 240,000 American men are diagnosed with prostate cancer every year. Your
More information1. What is the prostate-specific antigen (PSA) test?
1. What is the prostate-specific antigen (PSA) test? Prostate-specific antigen (PSA) is a protein produced by the cells of the prostate gland. The PSA test measures the level of PSA in the blood. The doctor
More informationReport with statistical data from 2007
2008 Cancer Program Annual Report with statistical data from 2007 Lake Cumberland Regional Hospital 305 Langdon Streett Somerset, KY 42503 Telephone: 606-679-7441 Fax: 606-678-9919 Cancer Committee Mullai,
More informationBreast Cancer Treatment Guidelines
Breast Cancer Treatment Guidelines DCIS Stage 0 TisN0M0 Tamoxifen for 5 years for patients with ER positive tumors treated with: -Breast conservative therapy (lumpectomy) and radiation therapy -Excision
More informationHow To Compare The Effects Of A Hysterectomy And A Hysterectomy
A RANDOMIZED TRIAL COMPARING RADICAL HYSTERECTOMY AND PELVIC NODE DISSECTION VS SIMPLE HYSTERECTOMY AND PELVIC NODE DISSECTION IN PATIENTS WITH LOW RISK EARLY STAGE CERVICAL CANCER A Gynecologic Cancer
More informationSUMMARY. Randolph Fillmore, Florida Science Communications
SUMMARY Randolph Fillmore, Florida Science Communications The H. Lee Moffitt Cancer Center held its first Advanced Prostate Cancer Collaboration roundtable discussion November 24, 2008. The roundtable
More informationThe Need for Accurate Lung Cancer Staging
The Need for Accurate Lung Cancer Staging Peter Baik, DO Thoracic Surgery Cancer Treatment Centers of America Oklahoma Osteopathic Association 115th Annual Convention Financial Disclosures: None 2 Objectives
More informationFor further information on screening and early detection of prostate cancer, see the Section entitled Screening for Prostate Cancer.
Prostate Cancer For many older men, prostate cancer may be present but never cause symptoms or problems and many men will die with their prostate cancer rather than of their prostate cancer. Yet it remains
More informationINOEL RIVERA 1812 North Mills Avenue Orlando, Florida 32803 (407) 897-3499
INOEL RIVERA 1812 North Mills Avenue Orlando, Florida 32803 (407) 897-3499 PERSONAL DATA Date of Birth: May 21, 1965 Place of Birth: Mayaguez, Puerto Rico Citizenship: U.S. Marital Status: Married to Carmen
More informationInnovations in Kidney Cancer
Innovations in Kidney Cancer Guest Expert: Harriet, MD Associate Professor of Medical Oncology Edward, MD Assistant Professor of Surgical Urology www.wnpr.org www.yalecancercenter.org Welcome to Yale Cancer
More informationSomething Old, Something New.
Something Old, Something New. Michelle A. Fajardo, D.O. Loma Linda University Medical Center Clinical Presentation 6 year old boy, presented with hematuria Renal mass demonstrated by ultrasound & CT scan
More informationNEWSLETTER Nicholas Brook Urology
For Appointments Call : 08 8267 2200 January/February 2014 NEWSLETTER Nicholas Brook Urology Latest Urology News Welcome to the Nicholas Brook Urology newsletter January 2014. Nick Brook Urology on Ward
More information855-DRSAMADI or 212-241-8779
SMART SURGERY NEWS MARCH 2013 Dr. David Samadi 855-DRSAMADI or 212-241-8779 YOUR PROSTATE CANCER NEWS PREVENTION DIAGNOSIS TREATMENT LIFE AFTER PROSTATE CANCER PREVENTION Prostate Cancer Need-to-Knows
More informationReport series: General cancer information
Fighting cancer with information Report series: General cancer information Eastern Cancer Registration and Information Centre ECRIC report series: General cancer information Cancer is a general term for
More informationTreating Prostate Cancer
Treating Prostate Cancer A Guide for Men With Localized Prostate Cancer Most men have time to learn about all the options for treating their prostate cancer. You have time to talk with your family and
More informationHERC Coverage Guidance Advanced Imaging for Staging of Prostate Cancer Disposition of Public Comments
Table of Contents Commenters... 1 Public Comments... 2 References Provided by Commenters... 6 Commenters Identification Stakeholder A Medical Imaging & Technology Alliance (MITA), Arlington, VA [Submitted
More informationImproving access and reducing costs of care for overactive bladder through a multidisciplinary delivery model
Improving access and reducing costs of care for overactive bladder through a multidisciplinary delivery model Trafford Crump, Ph.D. Department of Surgery, University of Calgary Presentation to: Canadian
More informationProstate cancer is the most common cause of death from cancer in men over age 75. Prostate cancer is rarely found in men younger than 40.
A.D.A.M. Medical Encyclopedia. Prostate cancer Cancer - prostate; Biopsy - prostate; Prostate biopsy; Gleason score Last reviewed: October 2, 2013. Prostate cancer is cancer that starts in the prostate
More information